Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,290.00, down by ₹6.00, or 0.26%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *